Analytic Investors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$58.3M Buy
649,114
+42,976
+7% +$3.73M 0.65% 44
2016
Q2
$51.3M Buy
606,138
+7,958
+1% +$653K 0.61% 50
2016
Q1
$49.2M Sell
598,180
-16,893
-3% -$1.36M 0.6% 49
2015
Q4
$48.8M Sell
615,073
-297,267
-33% -$22.7M 0.61% 45
2015
Q3
$65.6M Sell
912,340
-81,760
-8% -$6.13M 0.88% 34
2015
Q2
$77.8M Sell
994,100
-1,105,948
-53% -$89M 1.09% 27
2015
Q1
$172M Buy
2,100,048
+1,057,728
+101% +$90.9M 2.35% 3
2014
Q4
$94.9M Buy
1,042,320
+54,367
+6% +$4.78M 1.35% 16
2014
Q3
$82.7M Buy
987,953
+897,864
+997% +$73.6M 1.18% 19
2014
Q2
$7.08M Buy
90,089
+67,323
+296% +$5.43M 0.11% 148
2014
Q1
$1.83M Sell
22,766
-161
-0.7% -$12.7K 0.03% 297
2013
Q4
$1.87M Sell
22,927
-62,146
-73% -$5.06M 0.03% 250
2013
Q3
$6.43M Sell
85,073
-42,479
-33% -$3.38M 0.1% 171
2013
Q2
$9.82M Buy
+127,552
New +$10M 0.16% 163

Other funds holding PG

Analytic Investors's PG Position: Q3 2016 in Review

Analytic Investors increased its Procter & Gamble (PG) stake by 7.1% in Q3 2016, buying an estimated $3.73M and bringing the position to 649,114 shares worth $58.3M. The position accounts for 0.65% of the portfolio, ranked #44.

Analytic Investors first reported a position in PG in Q2 2013 and has held it in 14 quarters since. The position peaked at $172M in Q1 2015. 2,002 funds tracked by Wall St. Rank hold PG as of Q3 2016.

  • Analytic Investors held 649,114 shares of Procter & Gamble worth $58.3M as of Q3 2016.
  • Analytic Investors bought 42,976 Procter & Gamble shares in Q3 2016, an estimated $3.73M.
  • Procter & Gamble made up 0.65% of Analytic Investors's portfolio in Q3 2016, its #44 holding.
  • Analytic Investors first reported a position in Procter & Gamble in Q2 2013 and has held it in 14 quarters since.
  • Analytic Investors's Procter & Gamble position peaked at $172M in Q1 2015.
  • 2,002 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.